Page last updated: 2024-09-04

nps-568 and Chronic Kidney Diseases

nps-568 has been researched along with Chronic Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bala, G; Caveliers, V; Cosyns, B; Delvenne, E; Delvenne, P; Droogmans, S; Hostens, J; Lahoutte, T; Roosens, B; Schiettecatte, J; Somja, J; Van Camp, G1
Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H1

Reviews

1 review(s) available for nps-568 and Chronic Kidney Diseases

ArticleYear
CKD-MBD: impact on management of kidney disease.
    Clinical and experimental nephrology, 2007, Volume: 11, Issue:4

    Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins

2007

Other Studies

1 other study(ies) available for nps-568 and Chronic Kidney Diseases

ArticleYear
Echocardiographic integrated backscatter for assessing reduction of aortic valve calcifications by R-568 in a rat model of chronic kidney disease.
    Ultrasound in medicine & biology, 2013, Volume: 39, Issue:11

    Topics: Aniline Compounds; Animals; Aortic Valve; Bicuspid Aortic Valve Disease; Calcinosis; Echocardiography; Heart Defects, Congenital; Heart Valve Diseases; Image Interpretation, Computer-Assisted; Male; Phenethylamines; Propylamines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Systems Integration; Treatment Outcome

2013